Business Description
Bio-Works Technologies AB
ISIN : SE0007387089
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.71 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -5.65 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 74 | |||||
3-Year EBITDA Growth Rate | -2 | |||||
3-Year EPS without NRI Growth Rate | -2.5 | |||||
3-Year FCF Growth Rate | -5.9 | |||||
3-Year Book Growth Rate | -2.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.56 | |||||
9-Day RSI | 45.7 | |||||
14-Day RSI | 46.45 | |||||
6-1 Month Momentum % | -76.94 | |||||
12-1 Month Momentum % | -86.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.29 | |||||
Quick Ratio | 2.79 | |||||
Cash Ratio | 2.17 | |||||
Days Inventory | 217.48 | |||||
Days Sales Outstanding | 52.95 | |||||
Days Payable | 174.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.6 | |||||
Shareholder Yield % | -42.32 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.1 | |||||
Operating Margin % | -131 | |||||
Net Margin % | -129.45 | |||||
FCF Margin % | -136.7 | |||||
ROE % | -110.43 | |||||
ROA % | -77.65 | |||||
ROIC % | -374.68 | |||||
ROC (Joel Greenblatt) % | -2216.13 | |||||
ROCE % | -106.37 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.71 | |||||
PB Ratio | 1.81 | |||||
Price-to-Tangible-Book | 1.85 | |||||
EV-to-EBIT | -0.73 | |||||
EV-to-Forward-EBIT | -11.07 | |||||
EV-to-EBITDA | -0.74 | |||||
EV-to-Forward-EBITDA | -11.77 | |||||
EV-to-Revenue | 0.91 | |||||
EV-to-Forward-Revenue | 2.09 | |||||
EV-to-FCF | -0.67 | |||||
Price-to-Net-Current-Asset-Value | 1.85 | |||||
Price-to-Net-Cash | 4.32 | |||||
Earnings Yield (Greenblatt) % | -136.99 | |||||
FCF Yield % | -75.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bio-Works Technologies AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.842 | ||
EPS (TTM) (€) | -0.141 | ||
Beta | 1.57 | ||
Volatility % | 68.26 | ||
14-Day RSI | 46.45 | ||
14-Day ATR (€) | 0.025679 | ||
20-Day SMA (€) | 0.14825 | ||
12-1 Month Momentum % | -86.75 | ||
52-Week Range (€) | 0.0822 - 1.145 | ||
Shares Outstanding (Mil) | 38.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bio-Works Technologies AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bio-Works Technologies AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Bio-Works Technologies AB Frequently Asked Questions
What is Bio-Works Technologies AB(FRA:1BD)'s stock price today?
When is next earnings date of Bio-Works Technologies AB(FRA:1BD)?
Does Bio-Works Technologies AB(FRA:1BD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |